| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.008 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |